News Release

The next clinical revolution: How extracellular vesicles and exosomes are shaping mitochondrial and microbiome medicine

Strategies to target all diseases related to mitochondrial dysfunction and microbiota dysbiosis: Aging and longevity will depend on EVs and exosomes understanding

Meeting Announcement

Mitochondria-Microbiota Task Force

Malta Hosts First Targeting Extracellular Vesicles Conference This October: Bridging Mitochondria and  Microbiota Research

image: 

The First World Conference on Targeting Extracellular Vesicles, scheduled for October 17-18, 2024, at the Corinthia Palace in Malta, marks a strategic collaboration between the World Mitochondria Society and the International Society of Microbiota.

view more 

Credit: Targeting Extracellular Vesicles 2024

The First World Conference on Targeting Extracellular Vesicles, scheduled for October 17-18, 2024, at the Corinthia Palace in Malta, marks a strategic collaboration between the World Mitochondria Society and the International Society of Microbiota.

This event will focus on the transformative role of extracellular vesicles (EVs) and exosomes in the future of medicine, particularly through their interactions with mitochondria and microbiota.

 

Mitochondria and Extracellular Vesicles: Where are We Now & What’s Next

Mitochondria, the powerhouses of the cell, play a crucial role in cellular energy production and regulation. The conference will delve into how EVs and exosomes can influence mitochondrial dynamics, offering new insights into their potential for therapeutic innovation. Topics will include the role of mitovesicles in neurodegeneration, how mitochondrial-derived EVs can cross the blood-brain barrier, and the implications of mitochondrial DAMPs in neuroinflammatory responses. Additionally, advancements in engineering exosomes to specifically target mitochondria in brain cells highlight the promising future of mitochondrial medicine.

Microbiota and Extracellular Vesicles Insights & Perspectives

Microbiota, the community of microorganisms living in our bodies, are essential for maintaining health and preventing disease. The conference will explore how microbiota-derived EVs and exosomes impact health and disease, with a focus on the gut-liver axis, maternal-fetal health, and vaginal microbiota. The therapeutic applications of microbial EVs will also be a key topic, including their potential in mental health disorders, combating antimicrobial resistance, and promoting tissue regeneration. By bridging microbiota research with EV and exosome technology, the conference aims to unlock new pathways for innovative treatments and improved health outcomes.

 

Targeting Extracellular Vesicles 2024 Speakers Line-Up:

  • Consuelo Borrás, University of Valencia, Spain

Role of Stem Cell-Derived Extracellular Vesicles to Promote Successful Aging

  • Åsa B. Gustafsson, University of California San Diego, USA

Extracellular Vesicle Release of Mitochondria in Response to Lysosomal Dysfunction

  • Lanrong Bi, Michigan Technological University, USA

Engineering Exosomes for Precise Mitochondrial Targeting in Brain Cells: Expanding the Frontiers of Cellular Communication and Therapeutics

  • Ramaroson Andriantsitohaina, University of Montpellier, France

Targeting central regulation of obesity with EVs: Breakthrough Approach Nature Metabolism

  • Didier Serteyn, Université de Liège, Belgium

Exploring the Capabilities of Exosomes from Muscle-Derived Mesenchymal Stem Cells: Insights into Immunomodulation and Mitochondrial Transfer

  • Joachim Pius Spatz, University of Heidelberg, Germany

Bioinspired, Fully Synthetic Extracellular Vesicles to Optimize Wound Healing

  • Carla Lopes, University of Coimbra, Portugal

Mitochondrial DAMPs in EVs: Triggering Early Neuroinflammation in Neurodegeneration

  • Devika S. Manickam, Duquesne University, USA

Mouse vs. human cell-derived mitochondria containing extracellular vesicles for delivery to the blood-brain barrier

  • Seyed Davar Siadat, Pasteur Institute of Iran, Iran

The gut microbe-derived extracellular vesicles (GMEVs)- mitochondria axis in mental disorders: Strengths and weaknesses of new studies

  • Efrat Levy, NYU Grossman School of Medicine, USA

The Role of Mitovesicles in the Brain with Mitochondrial Dysfunction

  • Justus Reunanen, University of Oulu, Finland

Microbiota-Derived Extracellular Vesicles in Maternal-Fetal Communication: What We Know?

  • Lorraine O’Driscoll, Trinity College Dublin and Trinity St. James's Cancer Institute, Ireland

Cancer-related Extracellular Vesicles in relation to Mitochondria, Microbiota and More

  • Meta Kuehn, Duke University, USA

Modulation of Phage-Microbe interactions and Antimicrobial Resistance by Bacterial Extracellular Vesicles

  • Steven Jay, University of Maryland, USA

Therapeutic Applications of Microbial Extracellular Vesicles

  • Carola Parolin, University of Bologna, Italy

Lactobacilli Extracellular Vesicles: Potential Postbiotics to Support The Vaginal Microbiota Homeostasis

 

For more information about the conference, speakers, and topics, please visit www.targeting-exosomes.com, or contact us on info@targeting-exosomes.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.